How Cannabis and Tobacco Are Used Together in Spain — and What Withdrawal Looks Like

Among Spanish cannabis users seeking treatment, 88% mixed cannabis with tobacco, 76% experienced withdrawal symptoms, and women reported more severe withdrawal — with two distinct user profiles emerging.

Saura, Judith et al.·Addictive behaviors reports·2026·Moderate EvidenceCross-Sectional·1 min read
RTHC-08604Cross SectionalModerate Evidence2026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
N=94
Participants
N=94 participants aged 15-64, 50% female, from substance use treatment programs in Catalonia, Spain.

What This Study Found

This cross-sectional study of 94 participants entering cannabis use disorder treatment in Catalonia, Spain, documented the deeply intertwined nature of cannabis and tobacco use in a European context where mixing the two substances in "spliffs" is the dominant consumption method.

Daily tobacco use was reported by 91.5% of participants, with a mean Fagerström nicotine dependence score of 4.2 out of 10 (moderate dependence). Most participants (88.1%) co-used cannabis with tobacco in the same product. Cannabis withdrawal symptoms were experienced by 75.8%, with women reporting greater severity than men.

Cluster analysis revealed two distinct user profiles. Cluster 1 (71% of participants) represented one behavioral pattern, while Cluster 2 (29%) represented another — suggesting that cannabis-tobacco dual users are not a homogeneous group and may need different treatment approaches.

The findings highlight a complication that's particularly relevant in European cannabis culture: when cannabis and tobacco are co-administered in every use episode, quitting cannabis also means confronting nicotine withdrawal, and vice versa.

Key Numbers

94 participants. Daily tobacco use: 91.5%. Mean Fagerström score: 4.2/10. Cannabis-tobacco co-use: 88.1%. Cannabis withdrawal: 75.8% experienced symptoms. Women reported greater withdrawal severity. Two behavioral clusters: Cluster 1 (71%), Cluster 2 (29%).

How They Did This

Cross-sectional study in substance use treatment programs in Catalonia, Spain. 94 participants initiating CUD treatment. Questionnaire assessing sociodemographics, cannabis and tobacco use characteristics, nicotine dependence (Fagerström), motivation to quit, and cannabis withdrawal symptoms. Hierarchical cluster analysis using Gower's distance to identify behavioral profiles.

Why This Research Matters

The European pattern of mixing cannabis with tobacco in spliffs creates a dual dependence that's different from the North American pattern of using cannabis alone. Treatment programs designed for cannabis alone may miss the tobacco component, and tobacco cessation programs may not account for the cannabis dimension. Understanding these co-use patterns is essential for effective treatment in populations where mixing is the norm.

The Bigger Picture

This connects to the prenatal cannabis-tobacco review (RTHC-00239), which examined how both substances affect fetal development through overlapping epigenetic mechanisms. It also links to the cannabis withdrawal literature (RTHC-00037, RTHC-00249) by adding the complication of concurrent nicotine withdrawal. The finding that women experience more severe withdrawal echoes sex differences documented across multiple studies in this database (RTHC-00222, RTHC-00236, RTHC-00252).

What This Study Doesn't Tell Us

Cross-sectional design from a single treatment setting in Catalonia. The 94-participant sample is modest. Treatment-seeking individuals may not represent all dual users. European spliff culture differs from North American consumption patterns, limiting generalizability. Self-reported use measures may be imprecise.

Questions This Raises

  • ?Should cannabis treatment programs in spliff-culture countries include formal tobacco cessation components?
  • ?Do the two user profiles identified by cluster analysis require different treatment strategies?
  • ?Why do women experience more severe cannabis withdrawal — is this biological or related to different use patterns?

Trust & Context

Key Stat:
Evidence Grade:
Cross-sectional study from a treatment-seeking population — provides useful descriptive data on co-use patterns and withdrawal but cannot establish causal relationships.
Study Age:
Published in 2026, documenting current cannabis-tobacco co-use patterns in a European treatment context.
Original Title:
Consumption patterns and withdrawal symptoms in dual cannabis-tobacco users in Spain: Cross-sectional study.
Published In:
Addictive behaviors reports, 23, 100656 (2026)Addictive Behaviors Reports is a peer-reviewed journal focused on addiction research.
Database ID:
RTHC-08604

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-08604·https://rethinkthc.com/research/RTHC-08604

APA

Saura, Judith; Enríquez, Marta; Feliu, Ariadna; Roca, Xavier; Mondón, Silvia; Barrio, Pablo; Andreu, Magalí; Segura, Lidia; Ballbè, Montse; Fu, Marcela; Fernández, Esteve; Martínez, Cristina. (2026). Consumption patterns and withdrawal symptoms in dual cannabis-tobacco users in Spain: Cross-sectional study.. Addictive behaviors reports, 23, 100656. https://doi.org/10.1016/j.abrep.2025.100656

MLA

Saura, Judith, et al. "Consumption patterns and withdrawal symptoms in dual cannabis-tobacco users in Spain: Cross-sectional study.." Addictive behaviors reports, 2026. https://doi.org/10.1016/j.abrep.2025.100656

RethinkTHC

RethinkTHC Research Database. "Consumption patterns and withdrawal symptoms in dual cannabi..." RTHC-08604. Retrieved from https://rethinkthc.com/research/saura-2026-consumption-patterns-and-withdrawal

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.